Why the NHS should do more bariatric surgery; how much should we do? by Welbourn, R, le Roux, C, Owen-Smith, A, Wordsworth, S, Blazeby, J

Sensitivity of modelled fracture liaison service impact to subsequent fracture risk uncertainty by Pinedo-Villanueva, R, Thomas, T, Cortet, B, Paccou, J, Roux, C, Javaid, MK

Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis by Freemantle, N, Cooper, C, Diez-Perez, A, Gitlin, M, Radcliffe, H, Shepherd, S, Roux, C

Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. by Freemantle, N, Cooper, C, Diez-Perez, A, Gitlin, M, Radcliffe, H, Shepherd, S, Roux, C

Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years. by le Roux, C, Jenkins, P, Chew, S, Camacho-Hübner, C, Grossman, AB, Besser, G, Monson, J

EFFICACY OF DENOSUMAB RELATIVE TO OTHER OSTEOPOROSIS THERAPIES FOR PREVENTION OF FRACTURES IN POSTMENOPAUSAL OSTEOPOROSIS: RESULTS OF AN ADJUSTED INDIRECT AND MIXED TREATMENT COMPA... by Freemantle, N, Diez-Perez, A, Cooper, C, Man, H, Shepherd, S, Badamgarav, E, Gitlin, M, Roux, C

Trauma Type of Non-hip, Non-vertebral Fractures in Postmenopausal Women Being Treated for Osteoporosis in Europe. by Roux, C, Cooper, C, Ortolani, S, Diez-Perez, A, Horne, R, Franchimont, N, Easton, V, Freemantle, N

PREVALENT FRACTURES IN POSTMENOPAUSAL WOMEN BEING TREATED FOR OSTEOPOROSIS IN EUROPE: RELATIONSHIP BETWEEN TRAUMA TYPE, TIME RELATIVE TO MENOPAUSE, AND FRACTURE LOCATION by Roux, C, Cooper, C, Ortolani, S, Diez-Perez, A, Horne, R, Franchimont, N, Shepherd, S, Moeller, G, Freemantle, N

Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU® study by Roux, C, Cooper, C, Díez-Pérez, A, Martinez, L, Ortolani, S, Gitlin, M, Möller, G, Shepherd, S, Freemantle, N

Distribution of risk factors for fracture in women with and without a fracture history: A regional comparison. The global longitudinal registry of osteoporosis in women by Adachi, J, Compston, J, Cooper, C, Diez-Perez, A, Hooven, F, Netelenbos, J, Dedrick, R, Roux, C

Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU study. by Roux, C, Cooper, C, Díez-Pérez, A, Martinez, L, Ortolani, S, Gitlin, M, Möller, G, Shepherd, S, Freemantle, N

DISTRIBUTION OF RISK FACTORS FOR FRACTURE IN WOMEN WITH AND WITHOUT A FRACTURE HISTORY: A REGIONAL COMPARISON. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN by Diez-Perez, A, Adachi, J, Adami, S, Boonen, S, Chapurlat, R, Compston, J, Cooper, C, Roux, C, Silverman, S, Nika, G

RISK FACTORS FOR FRAGILITY FRACTURE IN A MULTIRACIAL COHORT OF US WOMEN. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN by Silverman, S, Roux, C, Adachi, J, Adami, S, Boonen, S, Chapurlat, R, Compston, J, Cooper, C, Diez-Perez, A, Wyman, A

FAILURE TO PERCEIVE INCREASED RISK OF FRACTURE IN WOMEN 55 YEARS AND OLDER. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN by Cooper, C, Siris, E, Adachi, J, Adami, S, Boonen, S, Chapurlat, R, Compston, J, Diez-Perez, A, Roux, C, Wyman, A

REGIONAL DIFFERENCES IN THE MANAGEMENT OF OSTEOPOROSIS. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN by Chapurlat, R, Lindsay, R, Adachi, J, Adami, S, Boonen, S, Compston, J, Cooper, C, Diez-Perez, A, Roux, C, Fitzgerald, G

Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study. by Alexandraki, K, Kaltsas, G, le Roux, C, Fassnacht, M, Ajodha, S, Christ-Crain, M, Akker, SA, Drake, WM, Edwards, R, Allolio, B, Grossman, AB

REASONS FOR STOPPING ANTI-OSTEOPOROSIS MEDICATIONS AMONG POSTMENOPAUSAL WOMEN: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN by Hooven, F, Roux, C, Adami, S, Boonen, S, Chapurlat, R, Compston, J, Cooper, C, Diez-Perez, A, Netelenbos, J, Pfeilschifter, J, Nika, G, Gehlbach, S, Investigators, GLOW

RISK FACTOR CHARACTERISTICS OF WOMEN WITH INCIDENT FRACTURES: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN by Hooven, F, Boonen, S, Adami, S, Chapurlat, R, Compston, J, Cooper, C, Diez-Perez, A, Netelenbos, J, Pfeilschifter, J, Roux, C, Nika, G, Gehlbach, S, Investigators, GLOW

Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications by Freemantle, N, Cooper, C, Roux, C, Díez-Pérez, A, Guillemin, F, Jonsson, B, Ortolani, S, Pfeilschifter, J, Horne, R, Kakad, S, Shepherd, S, Möller, G, Marciniak, A, Martinez, L

Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications. by Freemantle, N, Cooper, C, Roux, C, Díez-Pérez, A, Guillemin, F, Jonsson, B, Ortolani, S, Pfeilschifter, J, Horne, R, Kakad, S, Shepherd, S, Möller, G, Marciniak, A, Martinez, L